IGF1R and cancer: Genes involved in endocrine resistance pathways primarily fell into 3 functional categories: ERBB2/IGF1R, CCND1, and BCL2 (Fig. 3c, Supplementary Data 10 and 13), which have been reported to be associated with endocrine resistance15–17 and an increased risk of cancer recurrence in breast cancer18,19.